Maximum Dosing of Lithium
The maximum recommended daily dose of lithium carbonate for acute mania is 1800 mg/day (600 mg three times daily), targeting serum levels of 1.0–1.5 mEq/L, while maintenance therapy typically requires lower doses of 900–1200 mg/day to maintain levels of 0.6–1.2 mEq/L. 1
Acute Mania Dosing
For acute manic episodes, the FDA-approved maximum dosing is structured as follows:
- Standard dosing: 600 mg three times daily (1800 mg total daily dose) 1
- Target serum levels: 1.0–1.5 mEq/L during the acute phase 1
- Initiation strategy: Begin at 300 mg twice daily for most patients, or 450 mg twice daily if clinically stable and not elderly 2
- Monitoring frequency: Check serum levels twice weekly during acute treatment until stabilization is achieved 1
The therapeutic window is narrow, and doses must be adjusted based on both serum concentrations and clinical response rather than relying solely on laboratory values. 1
Maintenance Therapy Dosing
Once acute symptoms are controlled, lower doses are appropriate:
- Target serum levels: 0.6–1.2 mEq/L for long-term control 3, 1
- Typical maintenance doses by age group: 4
- Patients <40 years: 925–1300 mg daily
- Patients 40–60 years: 740–925 mg daily
- Patients >60 years: 550–740 mg daily
- Standard maintenance regimen: 300 mg three to four times daily (1200 mg total) 1
- Monitoring frequency: Every 3–6 months once stable 2, 5, 3
Critical Safety Thresholds
Toxicity occurs at levels >1.5 mEq/L, with severe toxicity at >2.5 mEq/L requiring immediate discontinuation and possible hemodialysis. 3
Key safety considerations include:
- Elderly patients often exhibit toxicity at levels of 1.0–1.5 mEq/L that are normally tolerated by younger adults and require reduced dosing 1
- Therapeutic range: 0.6–1.2 mEq/L (maintenance) versus toxic range >1.5 mEq/L represents a narrow margin 3
- Timing of blood draws: Obtain levels 8–12 hours after the last dose when concentrations are stable 1
Dosing Administration Strategies
- Twice-daily dosing with sustained-release formulations is well-established and improves compliance compared to three-times-daily regimens 4
- Single evening dose is recommended by some expert panels for modern sustained-release preparations 4
- Sustained-release formulations reduce peak plasma concentrations by 30–50% without changing total drug exposure, requiring target levels in the upper maintenance range (0.8–1.0 mEq/L rather than 0.6–0.8 mEq/L) 4
Common Pitfalls to Avoid
- Never make dose adjustments without medical supervision and serum level monitoring, as abrupt changes precipitate toxicity 3
- Do not rely exclusively on serum levels—accurate evaluation requires both clinical assessment and laboratory analysis 1
- Avoid abrupt discontinuation, which markedly raises relapse risk, particularly within the first 6 months, with relapse rates exceeding 80% after stopping lithium 3
- Renal insufficiency is a contraindication due to considerable reduction in lithium clearance 4